General Information
Version
CAT 797 - Fluoxetine Hydrochloride
Revision date
2023-10-30
Product name
Fluoxetine Hydrochloride
Substance name
C17H18F3NO HCL 345.79
Chemical name
Fluoxetine Hydrochloride
CAS No.
56296-78-7
1.2.1 Relevant identified uses
Laboratory use
supplier name
British Pharmacopoeia Commission
Emergency telephone
+44 (0)20 3080 6561
Icons in SDS
Company Information
company name
British Pharmacopoeia Commission
e-mail address of the competent person responsible for the Safety Data Sheet
bpcrs@mhra.gov.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H317, H318, H334, H336, H361, H361f, H362, H373, H400, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
2.2 Label elements
260-101-2
Contains
Fluoxetine Hydrochloride
Signal word
Danger
Hazard statements
H302 - Harmful if swallowed H317 - May cause an allergic skin reaction H318 - Causes serious eye damage H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled H336 - May cause drowsiness or dizziness H361f - Suspected of damaging fertility H362 - May cause harm to breast-fed children H373 - May cause damage to organs through prolonged or repeated exposure H410 - Very toxic to aquatic life with long lasting effects
Precautionary statements
P260 - Do not breathe dust/fume/gas/mist/vapours/spray P263 - Avoid contact during pregnancy and while nursing P273 - Avoid release to the environment P280 - Wear protective gloves/protective clothing/eye protection/face protection P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P310 - Immediately call a POISON CENTER or doctor P391 - Collect spillage
2.3 Other hazards
No information available. This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity - Oral Category 4 - (H302) Serious eye damage/eye irritation Category 1 - (H318) Respiratory sensitisation Category 1 - (H334) Skin sensitisation Category 1 - (H317) Reproductive toxicity Category 2 - (H361) Effects on or via lactation Yes - (H362) Specific target organ toxicity — single exposure Category 3 - (H336) Specific target organ toxicity — repeated exposure Category 2 - (H373) Acute aquatic toxicity Category 1 - (H400) Chronic aquatic toxicity Category 1 - (H410)
